Latent Tuberculosis in Healthcare Workers - the Reality of a Portuguese Tertiary Hospital

Last updated: April 27, 2023
Sponsor: Centro Hospitalar do Oeste
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hiv

Lung Disease

Treatment

IGRA/Tuberculin skin test

Clinical Study ID

NCT05847491
LTBCHO23
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Prospective, descriptive study to assess latent tuberculosis infection (LTBI) among healthcare worker (HCW) in a tertiary hospital in a low-risk area.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All HCW from our hospital with risk of exposure, working in our hospital for at least 3 consecutive months
  • Acceptance to participate and signed informed consent form

Exclusion

Exclusion Criteria:

  • History of previous tuberculosis
  • Active Tuberculosis
  • Refusal to sign the informed consent form

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: IGRA/Tuberculin skin test
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
December 31, 2023

Study Description

identification and treatment of LTBI can substantially reduce the risk of development of disease and are important TB control strategies, especially in settings with a low tuberculosis (TB) incidence, where reactivation of LTBI often accounts for the majority of non-imported TB disease treatment of LTBI can substantially reduce the risk of development of disease.

In Portugal the real prevalence of LTBI in low-risk HCWs has not been evaluated since they are not included in the periodic screening programs. It is important to diagnose TB infections in HCWs to prevent nosocomial transmission, particularly among immunocompromised patients.

The risk for transmission varies by setting, occupational group, local prevalence of TB, patient population, and effectiveness of TB infection control measures.

Prevention of active TB disease by treatment of LTBI is a critical component for public health.

Tuberculin skin test (TST) is used worldwide to diagnose LTBI, whereas interferon-γ release assay (IGRA) are used in some countries according to their national TB programs. IGRA offers a potential method of serial testing to diagnose LTBI in HCWs, and it has better specificity than that of TST in one-time screening.

Study participants should be identified and contacted by occupational health service. In association, study information should be disseminated through posters and institutional email.

Connect with a study center

  • Centro Hospitalar do Oeste - Torres Vedras

    Torres Vedras, Lisboa 2560-295
    Portugal

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.